Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (17%) |
| §101 + other | 2 (33%) |
| §102 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SNOW, BRUCE EDWARD | 1 | 75.3% | +8.2% |
| BELLAH, JEFFREY LAWRENCE | 1 | — | — |
| KONOPELSKI SNAVEL, SARA ELIZABETH | 1 | 30.0% | +38.8% |
| SHOWALTER, ALEXANDER KEITH | 1 | 53.6% | +32.5% |
| STEADMAN, DAVID J | 1 | 57.7% | +29.5% |
| ROONEY, NORA MAUREEN | 1 | 60.2% | +23.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18562893 | MOLECULAR SIGNATURE FOR ASSESSING THE RESPONSIVENESS OF CANCER TO MITOCHONDRIA-TARGETED ANTIOXIDANTS | BELLAH, JEFFREY LAWRENCE | — |
| 18263756 | POLYPEPTIDE INHIBITORS OF LACTATE DEHYDROGENASE ACTIVITY FOR USE IN CANCER THERAPY | KONOPELSKI SNAVEL, SARA ELIZABETH | — |
| 17920560 | ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR THE TREATMENT OF SPLEEN DISORDERS | SHOWALTER, ALEXANDER KEITH | — |
| 17608002 | LACTATE DEHYDROGENASE INHIBITOR POLYPEPTIDES FOR USE IN THE TREATMENT OF CANCER | ROONEY, NORA MAUREEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17792011 | GENETICALLY MODIFIED BACTERIUM WITH ALTERED ENVELOP INTEGRITY AND USES THEREOF | STEADMAN, DAVID J | 26d |
| 18263756 | POLYPEPTIDE INHIBITORS OF LACTATE DEHYDROGENASE ACTIVITY FOR USE IN CANCER THERAPY | KONOPELSKI SNAVEL, SARA ELIZABETH | — |
| 17920560 | ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR THE TREATMENT OF SPLEEN DISORDERS | SHOWALTER, ALEXANDER KEITH | — |
| 17608002 | LACTATE DEHYDROGENASE INHIBITOR POLYPEPTIDES FOR USE IN THE TREATMENT OF CANCER | ROONEY, NORA MAUREEN | — |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| 1658 | 1 |
| 1629 | 1 |
| 1656 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18843768 | DEVICE FOR HEART VALVE REPAIR | SNOW, BRUCE EDWARD | — | §102 | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18562893 | MOLECULAR SIGNATURE FOR ASSESSING THE RESPONSIVENESS OF CANCER TO MITOCHONDRIA-TARGETED ANTIOXIDANTS | BELLAH, JEFFREY LAWRENCE | 1683 | §101 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18263756 | POLYPEPTIDE INHIBITORS OF LACTATE DEHYDROGENASE ACTIVITY FOR USE IN CANCER THERAPY | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §101§102§112 | Non-Final OA | — | Pending | Aug 01, 2023 |
| 17920560 | ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR THE TREATMENT OF SPLEEN DISORDERS | SHOWALTER, ALEXANDER KEITH | 1629 | §102§103§112Other | Non-Final OA | — | Pending | Oct 21, 2022 |
| 17792011 | GENETICALLY MODIFIED BACTERIUM WITH ALTERED ENVELOP INTEGRITY AND USES THEREOF | STEADMAN, DAVID J | 1656 | §103DP | Non-Final OA | 26d | Pending | Jul 11, 2022 |
| 17608002 | LACTATE DEHYDROGENASE INHIBITOR POLYPEPTIDES FOR USE IN THE TREATMENT OF CANCER | ROONEY, NORA MAUREEN | 1641 | §101§102§112 | Non-Final OA | — | Pending | Nov 01, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial